Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Connecticut Updates Cancer Coverage for Firefighters

In addition to now covering skin cancer, the state will handle cancer cases differently and adjust the five-year service requirement.
Read More →
May 19, 2025

ACOEM Webinar to Cover Cannabis Guidelines

The May 21st webinar will examine medical literature on cannabis for acute, chronic, and postoperative pain.
Read More →
May 19, 2025

Congressional Budget Bill Would Place a 10-Year Ban on State AI Regulations

If passed with this recent amendment, the bill would prevent the enforcement of laws on AI models and automated decision systems.
Read More →
May 19, 2025

Vermont Proposes Worker Safety Bill for Extreme Temperatures

The bill would recognize temperatures above 80°F or below 60°F as extreme temperatures, with exemptions for short-term exposure.
Read More →
May 12, 2025

Michigan Introduces Infectious Disease Bill

The bill proposes an infectious disease worker safety commission to determine best practices during an emergency declared due to infectious disease.
Read More →
May 12, 2025

Louisiana Fee Schedule Bill Passes House, Moves to Senate

If enacted, House Bill 117 would trigger the first update to the Louisiana workers’ comp fee schedule in 30 years.
Read More →
May 12, 2025

New Mexico Enacts Psychedelic Therapy Bill

Senate Bill 219 allows for psilocybin therapy for the treatment of PTSD, treatment-resistant depression, and more.
Read More →
May 12, 2025

WCRI Reports On the Impact Of Marijuana Laws On Workers’ Comp Benefits

While recreational marijuana laws may be tied to increases in claim frequency, medical payments and prescriptions decreased, including those for opioids.
Read More →
May 5, 2025

Wisconsin Workers’ Compensation Advisory Council Meeting Recap

Topics discussed include proposals for a fee schedule by 2027, employer direction of care, and allowing more providers to provide disability opinions.
Read More →
May 5, 2025
1 … 25 26 27 28 29 … 49

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

AMA Updates Impairment Rating Guidelines for the First Time Since 2008

Changes center around improving the assessment of mental and behavioral impairment.
Read More

More Recreational Marijuana Legalization, More Positive Workplace Drug Tests

Connecticut legalizes recreational use, and NCCI expects even more states to follow suit.
Read More

Interstate Variation and Trends in Workers’ Comp Drug Payments

A new flash report from the WCRI highlights trends in drug utilization.
Read More

Mental Health Injuries Gain Momentum in Workers’ Comp

Corrections officers in Nebraska benefit from a new law; will healthcare workers in Connecticut join them?
Read More

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.
Read More

FDA Revokes Emergency Use Authorization for Bamlanivimab for COVID-19

Due to mutating viral strains, the potential benefits of this COVID-19 drug no longer outweigh the risks.
Read More
1 … 25 26 27 28 29 … 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle